TRANS GENIC GROUP INC. (2342)

Market cap
¥4.8B
P/E ratio
117.9x
Transgenics Group supports drug development through specialized lab services like genetically modified mice production and pharmaceutical testing, while also providing business consulting and importing various products from electrical equipment to tableware.
Period EndProperty, plant and equipment, net (Million JPY)YoY (%)
Mar 31, 20252,055-4.07%
Mar 31, 20242,142+7.56%
Mar 31, 20231,992-0.05%
Mar 31, 20221,993-6.23%
Mar 31, 20212,125+2.67%
Mar 31, 20202,070-4.25%
Mar 31, 20192,162+43.24%
Mar 31, 20181,509+2.24%
Mar 31, 20171,476+3.33%
Mar 31, 20161,429+1.54%
Mar 31, 20151,407
AI Chat